Muzero Acquisition Corp - Warrant (MUZEW)

On our desk, we are observing MUZEW trading sideways in a very narrow band between support at $0.29 and resistance at $0.33. The lack of movement isn't necessarily bearish; it's classic wait-and-see behavior while the market looks for a concrete merger catalyst from the Muzero Acquisition team.

Looking at the Q2 2026 institutional filings, 39 hedge funds and large institutions have deployed approximately $2.33 million into MUZEW warrants. With 20 funds opening new positions versus only 2 exits, the smart money accumulation trend is apparent even if the price action remains flat at $0.31.

When evaluating the structural mechanics of MUZEW, remember that the units separated back on March 23, 2026. Each unit split into one Class A ordinary share (MUZE) and one-half of a redeemable warrant, with only whole warrants trading under MUZEW. Fractional components were omitted, so tracking whole-warrant liquidity is vital.

As a risk manager, I am closely watching the February 2028 regulatory deadline. Muzero Acquisition Corp completed its $201 million IPO in early 2026, but with zero operating revenue currently, the entire value thesis rests on successfully completing a technology-enabled business combination within Nasdaq's allowed timeframe before liquidation risk kicks in.

Our bio-analyst and tech-SPAC desk notes point out that Muzero's stated focus on a 'technology-enabled business combination' leaves the sector scope broad. Investors holding warrants at $0.31 are essentially buying a long-dated option on management's ability to source a high-growth asset before the search window closes.